---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-074577"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2026-06-16T20:06:02+00:00"
generated_at: "2026-06-16T20:08:52.567048+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics CSO Chad Cowan moves to part-time with reduced salary

## Summary
- Chad Cowan continues as CSO on part-time basis; salary cut to $296,150 annually.
- Eligible for pro-rated annual performance-based target bonus.
- Upon company termination or resignation, entitled only to accrued unpaid base salary.
- A&R Employment Agreement to be filed as exhibit to Q2 2026 10-Q.
- Agreement effective June 15, 2026.

## SEC filing metadata
- accession: 0001104659-26-074577
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2026-06-16T20:06:02+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465926074577/0001104659-26-074577-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465926074577/tm2617925d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-074577
- JSON: https://secwatch.observer/filing/0001104659-26-074577.json
- Plain text: https://secwatch.observer/filing/0001104659-26-074577.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.